DiagnaMed Acquires Strategic Ontario Claims Adjacent to QIMC in Premier Temiscamingue Hydrogen District
DiagnaMed Holdings (DGNMF) has acquired 91 unpatented mineral claims totaling 1,820 hectares in Ontario's Temiscamingue hydrogen district, adjacent to Quebec Innovative Materials Corp's (QIMC) project area. The strategic acquisition positions DiagnaMed to advance its proprietary hydrogen extraction technologies in one of Canada's most promising natural hydrogen regions.
The deal terms include a $25,000 non-refundable payment and the issuance of 12.5 million common shares. The sellers receive a 2% royalty on revenues from hydrogen or mineral sales, with an option for DiagnaMed to purchase 50% of the royalty for $2 million. The acquisition aims to foster collaboration with QIMC and accelerate technology commercialization in the region.
DiagnaMed Holdings (DGNMF) ha acquisito 91 concessioni minerarie non brevettate per un totale di 1.820 ettari nel distretto dell'idrogeno di Temiscamingue in Ontario, adiacente all'area di progetto di Quebec Innovative Materials Corp (QIMC). Questa acquisizione strategica posiziona DiagnaMed per sviluppare le sue tecnologie proprietarie di estrazione dell'idrogeno in una delle regioni naturali di idrogeno più promettenti del Canada.
I termini dell'accordo prevedono un pagamento non rimborsabile di 25.000 dollari e l'emissione di 12,5 milioni di azioni ordinarie. I venditori riceveranno una royalty del 2% sui ricavi derivanti dalla vendita di idrogeno o minerali, con un'opzione per DiagnaMed di acquistare il 50% della royalty per 2 milioni di dollari. L'acquisizione mira a favorire la collaborazione con QIMC e ad accelerare la commercializzazione della tecnologia nella regione.
DiagnaMed Holdings (DGNMF) ha adquirido 91 concesiones minerales no patentadas que suman 1.820 hectáreas en el distrito de hidrógeno de Temiscamingue en Ontario, adyacente al área de proyecto de Quebec Innovative Materials Corp (QIMC). Esta adquisición estratégica posiciona a DiagnaMed para avanzar en sus tecnologías propietarias de extracción de hidrógeno en una de las regiones naturales de hidrógeno más prometedoras de Canadá.
Los términos del acuerdo incluyen un pago no reembolsable de 25.000 dólares y la emisión de 12,5 millones de acciones ordinarias. Los vendedores recibirán un regalía del 2% sobre los ingresos de ventas de hidrógeno o minerales, con una opción para que DiagnaMed compre el 50% de la regalía por 2 millones de dólares. La adquisición busca fomentar la colaboración con QIMC y acelerar la comercialización de la tecnología en la región.
DiagnaMed Holdings (DGNMF)는 온타리오의 템이스카밍 수소 지구에 위치한 1,820헥타르 규모의 91개의 특허 미등록 광물 채굴권을 인수했습니다. 이 지역은 Quebec Innovative Materials Corp(QIMC)의 프로젝트 구역과 인접해 있습니다. 이번 전략적 인수로 DiagnaMed는 캐나다에서 가장 유망한 천연 수소 지역 중 하나에서 독자적인 수소 추출 기술을 발전시킬 수 있게 되었습니다.
거래 조건에는 25,000달러의 환불 불가 지급금과 1,250만 주의 보통주 발행이 포함되어 있습니다. 판매자는 수소 또는 광물 판매 수익에 대해 2% 로열티를 받으며, DiagnaMed는 200만 달러에 로열티의 50%를 구매할 수 있는 옵션을 가집니다. 이번 인수는 QIMC와의 협력을 촉진하고 해당 지역에서 기술 상용화를 가속화하는 데 목적이 있습니다.
DiagnaMed Holdings (DGNMF) a acquis 91 concessions minières non brevetées totalisant 1 820 hectares dans le districte hydrogène de Temiscamingue en Ontario, adjacent à la zone de projet de Quebec Innovative Materials Corp (QIMC). Cette acquisition stratégique positionne DiagnaMed pour développer ses technologies propriétaires d'extraction d'hydrogène dans l'une des régions naturelles d'hydrogène les plus prometteuses du Canada.
Les modalités de l'accord comprennent un paiement non remboursable de 25 000 $ et l'émission de 12,5 millions d'actions ordinaires. Les vendeurs recevront une redevance de 2 % sur les revenus issus des ventes d'hydrogène ou de minéraux, avec une option pour DiagnaMed d'acheter 50 % de la redevance pour 2 millions de dollars. Cette acquisition vise à favoriser la collaboration avec QIMC et à accélérer la commercialisation de la technologie dans la région.
DiagnaMed Holdings (DGNMF) hat 91 nicht patentierte Mineralienansprüche mit insgesamt 1.820 Hektar im Wasserstoffbezirk Temiscamingue in Ontario erworben, angrenzend an das Projektgebiet von Quebec Innovative Materials Corp (QIMC). Diese strategische Akquisition positioniert DiagnaMed, um seine proprietären Wasserstoff-Extraktionstechnologien in einer der vielversprechendsten natürlichen Wasserstoffregionen Kanadas voranzutreiben.
Die Vertragsbedingungen beinhalten eine nicht erstattungsfähige Zahlung von 25.000 US-Dollar sowie die Ausgabe von 12,5 Millionen Stammaktien. Die Verkäufer erhalten eine 2%ige Lizenzgebühr auf Einnahmen aus dem Verkauf von Wasserstoff oder Mineralien, mit einer Option für DiagnaMed, 50% der Lizenzgebühr für 2 Millionen US-Dollar zu erwerben. Die Akquisition zielt darauf ab, die Zusammenarbeit mit QIMC zu fördern und die Kommerzialisierung der Technologie in der Region zu beschleunigen.
- Strategic acquisition of 1,820 hectares adjacent to QIMC's project in a prime hydrogen district
- Potential operational synergies and technical collaboration with QIMC
- Location in favorable geological conditions for natural hydrogen generation
- Option to reduce royalty burden by 50% for $2 million
- Significant share dilution through issuance of 12.5 million common shares
- 2% revenue royalty obligation on all hydrogen and mineral sales
- Initial cash outlay of $25,000 required
TORONTO, May 29, 2025 (GLOBE NEWSWIRE) -- DiagnaMed Holdings Corp. (“DiagnaMed” or the “Company”) (CSE: DMED) (OTCQB: DGNMF), a Canadian technology innovator specializing in advanced hydrogen extraction technologies, is pleased to announce the strategic acquisition of claims located adjacent to Quebec Innovative Materials Corp. (“QIMC”) (CSE: QIMC) (OTCQB: QIMCF), comprising 91 unpatented, single-cell mineral claims, each cell approximately 20 hectares in size, totaling an area of 1820 hectares, within Ontario’s highly prospective Temiscamingue hydrogen district and graben. This acquisition positions DiagnaMed prominently within one of Canada's most promising natural hydrogen regions, providing an ideal environment to advance testing, validation, and commercialization of the Company’s proprietary hydrogen extraction technologies and exploration model.
The newly acquired claims are situated directly adjacent to QIMC’s project area, allowing for operational synergies and technical collaboration. The Temiscamingue region is widely recognized for its favorable geological conditions conducive to substantial natural hydrogen generation, offering significant potential for DiagnaMed’s technology validation and commercial development.
Under the terms of the acquisition agreement, the Company is required to make a non-refundable
Fabio Chianelli, CEO of DiagnaMed, stated, "We are extremely excited about this strategic acquisition, which firmly places DiagnaMed at the heart of a key Canadian natural hydrogen hub. The proximity to QIMC, a leader in natural hydrogen exploration and development, offers unique collaborative opportunities, enabling us to efficiently accelerate the commercialization of our innovative hydrogen extraction technology. We anticipate that this initiative will significantly enhance our competitive edge and pave the way for broader market opportunities."
John Karagiannidis, President of Quebec Innovative Materials Corp., commented, "We warmly welcome DiagnaMed into the Temiscamingue hydrogen district. This acquisition is timely and synergistic, aligning perfectly with our ongoing exploration efforts in Ontario. We believe that DiagnaMed’s technology and strategic vision will complement QIMC’s proven exploration model, fostering a dynamic environment that accelerates innovation and commercialization in this promising region."
Both DiagnaMed and QIMC are committed to sustainable energy solutions and leveraging Canada's significant geological resources to meet increasing global demand for clean energy.
About DiagnaMed
DiagnaMed Holdings Corp. (CSE: DMED) (OTCQB: DGNMF) is a Canadian technology innovator specializing in advanced hydrogen extraction technologies designed to support the rapidly growing natural hydrogen industry. Focused on commercial scalability, DiagnaMed aims to deliver cost-effective, sustainable, and efficient hydrogen solutions critical for global energy security and decarbonization. Visit DiagnaMed.com.
For more information, please contact:
Fabio Chianelli
Chairman and CEO
DiagnaMed Holdings Corp.
Tel: 416-800-2684
Email: info@diagnamed.com
Website: www.diagnamed.com
Neither the Canadian Securities Exchange nor its Regulation Services Provider have reviewed or accept responsibility for the adequacy or accuracy of this release.
Cautionary Statement
Certain statements in this news release are forward-looking statements, including with respect to future plans, and other matters. Forward-looking statements consist of statements that are not purely historical, including any statements regarding beliefs, plans, expectations or intentions regarding the future. Such information can generally be identified by the use of forwarding-looking wording such as “will”, “may”, “expect”, “could”, “can”, “estimate”, “anticipate”, “intend”, “believe”, “projected”, “aims”, and “continue” or the negative thereof or similar variations. The reader is cautioned that assumptions used in the preparation of any forward-looking information may prove to be incorrect. Events or circumstances may cause actual results to differ materially from those predicted, as a result of numerous known and unknown risks, uncertainties, and other factors, many of which are beyond the control of the Company, including but not limited to, business, economic and capital market conditions, the ability to manage operating expenses, and dependence on key personnel. Such statements and information are based on numerous assumptions regarding present and future business strategies and the environment in which the Company will operate in the future, anticipated costs, and the ability to achieve goals. Factors that could cause the actual results to differ materially from those in forward-looking statements include, the continued availability of capital and financing, litigation, failure of counterparties to perform their contractual obligations, loss of key employees and consultants, and general economic, market or business conditions. Factors that could cause actual results to differ materially from those anticipated in these forward-looking statements are described under the caption “Risk Factors” in Company’s management’s discussion and analysis for the Three and Six Months Ended March 31, 2025 (“MD&A”), dated May 28, 2025, which is available on the Company's profile at www.sedarplus.ca. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement. The reader is cautioned not to place undue reliance on any forward-looking information. The forward-looking statements contained in this news release are made as of the date of this news release. Except as required by law, the Company disclaims any intention and assumes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
This news release does not constitute an offer to sell or a solicitation of an offer to buy nor shall there be any sale of any of the securities in any jurisdiction in which such offer, solicitation or sale would be unlawful, including any of the securities in the United States of America. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the “1933 Act”) or any state securities laws and may not be offered or sold within the United States or to, or for account or benefit of, U.S. Persons (as defined in Regulation S under the 1933 Act) unless registered under the 1933 Act and applicable state securities laws, or an exemption from such registration requirements is available.
FAQ
What did DiagnaMed (DGNMF) acquire in the Temiscamingue hydrogen district?
What are the terms of DiagnaMed's Temiscamingue acquisition?
How will the Temiscamingue acquisition benefit DiagnaMed?
What is the relationship between DiagnaMed and QIMC in the Temiscamingue project?
